Primecap Management CO Novartis Ag Call Options Transaction History
Primecap Management CO
- $122 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NVS
# of Institutions
1,560Shares Held
136MCall Options Held
1.72MPut Options Held
1.7M-
Dodge & Cox San Francisco, CA10.6MShares$1.32 Billion0.78% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.12 Billion0.26% of portfolio
-
Morgan Stanley New York, NY7.56MShares$938 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.12MShares$884 Million0.35% of portfolio
-
Loomis Sayles & CO L P5.58MShares$693 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $267B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...